Armstrong Advisory Group’s Boston Scientific BSX Stock Holding History

Armstrong Advisory Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$301K	Sell	7,041 -1,481	-17%	-$80.4K	0.02%	204
2026 Q1	$535K	Sell	8,522 -381	-4%	-$30.5K	0.04%	135
2025 Q4	$849K	Sell	8,903 -101	-1%	-$9.9K	0.06%	98
2025 Q3	$879K	Buy	9,004 +69	+0.8%	+$7.15K	0.06%	91
2025 Q2	$960K	Buy	8,935 +4,857	+119%	+$491K	0.07%	72
2025 Q1	$364K	Hold	4,078	–	–	0.03%	134
2024 Q4	$364K	Sell	4,078 -724	-15%	-$63.7K	0.03%	134
2024 Q3	$402K	Sell	4,802 -64	-1%	-$5.04K	0.03%	121
2024 Q2	$375K	Sell	4,866 -595	-11%	-$43.6K	0.03%	121
2024 Q1	$316K	Hold	5,461	–	–	0.03%	134
2023 Q4	$316K	Hold	5,461	–	–	0.03%	134
2023 Q3	$288K	Hold	5,461	–	–	0.03%	130
2023 Q2	$295K	Hold	5,461	–	–	0.03%	129
2023 Q1	$273K	Hold	5,461	–	–	0.03%	134
2022 Q4	$253K	Buy	+5,461	New	+$236K	0.03%	142

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Armstrong Advisory Group's BSX Position: Q2 2026 in Review

Armstrong Advisory Group reduced its Boston Scientific (BSX) stake by 17% in Q2 2026, selling an estimated $80.4K and leaving 7,041 shares worth $301K. The position accounts for 0.02% of the portfolio, ranked #204.

Armstrong Advisory Group first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $960K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Armstrong Advisory Group held 7,041 shares of Boston Scientific worth $301K as of Q2 2026.
Armstrong Advisory Group sold 1,481 Boston Scientific shares in Q2 2026, an estimated $80.4K.
Boston Scientific made up 0.02% of Armstrong Advisory Group's portfolio in Q2 2026, its #204 holding.
Armstrong Advisory Group first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
Armstrong Advisory Group's Boston Scientific position peaked at $960K in Q2 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.